MZPhar SRL
1.0 FTEThe score of MZPhar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +350 % Total assets +1177 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MZPhar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
MZPhar's financial analysis
- Solvency20.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MZPhar
MZPhar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0780.885.533
- VAT number
- BE0780885533
- Peppol
- Registered · 0208:0780885533 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jan 2022
- Registered office
- 6210 Les Bons Villers
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MZPhar (SRL) has been based in Les Bons Villers since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,924 € and equity of 105,792 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 20.4%, below the median of its sector (41.5%).
Companies similar to MZPhar
Companies in the same business, of comparable size and area, outside its group.
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- Berghman Business and other management consultancy activities Wervik · balance sheet 426,772 €
- Pharmacie Simon Collard Retail sale of pharmaceutical products Waremme · balance sheet 647,936 €
- DUGO Retail sale of pharmaceutical products Zuienkerke · balance sheet 419,728 €
- Libo Consult Retail sale of pharmaceutical products Halen · balance sheet 516,567 €
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- Farmacie Henri Retail sale of pharmaceutical products Edegem · balance sheet 635,645 €
- Futurophar Retail sale of pharmaceutical products Ghent · balance sheet 394,606 €
Frequently asked questions about MZPhar
What is the revenue of MZPhar?
MZPhar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MZPhar?
In Belgium, the VAT number is the company number prefixed with BE: BE0780885533 for MZPhar, if the company is VAT-registered. Its company number (CBE) is 0780.885.533.
Where is the registered office of MZPhar?
According to the CBE register, the registered office of MZPhar is in 6210 Les Bons Villers.
What is the equity of MZPhar?
At the close of the 2025 financial year, the equity of MZPhar amounts to 105,792 €, a solvency of 20.4% of total assets.
How many people work at MZPhar?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MZPhar?
The register lists 1 active mandates at MZPhar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MZPhar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →